Role of cancer cell-stroma interaction in invasive growth of cancer cells

被引：39

作者：

Hiroaki Kataoka

Hiroyuki Tanaka

Koki Nagaike

Shuichiro Uchkama

Hiroshi Itoh

机构：

[1] Second Department of Pathology, Miyazaki Medical College, 5200 Kihara, Kiyotake, Miyazaki

来源：

Human Cell | 2003年 / 16卷 / 1期

关键词：

CD147; EMMPRIN; HAI-1; hepatocyte growth factor; HGF activator; invasion; matriptase; metastasis;

D O I：

10.1111/j.1749-0774.2003.tb00123.x

中图分类号：

学科分类号：

摘要：

Invasive growth is one of the hallmarks of cancer malignancy. To date, a significant body of evidence is accumulating in favor of the notion that invasive growth results from the cross-talk between cancer cells and the host stromal cells, comprising fibroblasts (myofibroblasts), endothelial cells, and leukocytes, all of which are themselves invasive. In this review we describe cross-talk between invasive cancer cells and host stromal fibroblasts and an impact of pericellular microenvironment on the invasive phenotype of cancer cells, focusing on two molecules, extracellular matrix metalloproteinase inducer (EMMPRIN, also known as tumor cell-derived collagenase stimulatoty factor, basigin, CD147) and hepatocyte growth factor (HGF, also known as scatter factor). Both molecules are deeply involved in the regulation of invasion-associated cellular activities, such as pencellular proteolysis, migration and ectopic sunrival of cancer cells. © 2003, Society and Springer Japan.

引用

页码：1 / 14

页数：13

共 89 条

[71]

Kataoka H., Miyata S., Uchinokura S., Et al., Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor, Cancer Metast. Rev., 22, pp. 223-236, (2003)

[72]

Takeuchi T., Harris J.L., Huang W., Et al., Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates, J. Biol. Chem., 275, pp. 26333-26342, (2000)

[73]

Oberst M., Anders J., Xie B., Et al., Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo, Am. J. Pathol., 158, pp. 1301-1311, (2001)

[74]

Oberst M.D., Johnson M.D., Dickson R.B., Et al., Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: Correlation with clinical outcome and tumor clinicopathological parameters, Clin. Cancer Res., 8, pp. 1101-1107, (2002)

[75]

Lin C.Y., Anders J., Johnson M., Et al., Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity, J. Biol. Chem., 274, pp. 18231-18236, (1999)

[76]

Ihara S., Miyoshi E., KO J., Et al., Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding α1-6GlcNAc branching, J. Biol. Chem., 277, pp. 16960-16967, (2002)

[77]

Shimomura T., Denda K., Kitamura A., Et al., Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor, J. Biol. Chem., 272, pp. 6370-6376, (1997)

[78]

Kawaguchi T., Qin L., Shimomura T., Et al., Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor, J. Biol. Chem., 272, pp. 27558-27564, (1997)

[79]

Lin C.Y., Anders J., Johnson M., Et al., Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk, J. Biol. Chem., 274, pp. 18237-18242, (1999)

[80]

Kataoka H., Itoh H., Shimomura T., Et al., Regulation of hepatocyte growth factor (HGF) activation on cell surface: Insights into an emerging class of cell surface protease inhibitors, Int. Archiv Cell Biol., 1, pp. 1036-1042, (2001)

← 1 2 3 4 5 6 7 8 9 →